Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01632332
Recruitment Status : Unknown
Verified April 2014 by Keith Knutson, Ph.D., Mayo Clinic.
Recruitment status was:  Active, not recruiting
First Posted : July 2, 2012
Last Update Posted : April 9, 2014
Tapimmune Inc.
Information provided by (Responsible Party):
Keith Knutson, Ph.D., Mayo Clinic

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2015
  Study Completion Date : No date given